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Recently, a large number of antibodies have been utilized as
biodrugs, and their subcutaneous formulations are required to
allow the self-administration. However, because of the lower
administration capacity of subcutaneous formulation than in-
travenous ones, highly-concentrated antibody formulations
(>100 mg/mL) are desired. Regretfully, highly-concentrated an-
tibodies often cause aggregation during the long-term storage
and transportation, resulting in the loss of pharmacological ac-
tivity and induction of immunogenicity. On the other hand, we
previously reported the potential use of polypseudorotaxane
(PPRX) hydrogels consisting of polyethylene glycol (PEG, MW
20,000) and cyclodextrins (CyDs) as sustained release systems
for protein drugs such as insulin and lysozyme. Therefore, in
the present study, we evaluated the stabilizing effects of CyD
PPRX hydrogels on the aggregation of highly-concentrated
human immunoglobulin G (IgG) or various antibody
preparations [1].
To prepare PPRX hydrogels, α-CyD solution (145 mg/mL) or
γ-CyD solution (232 mg/mL) including human IgG (130 mg/
mL) or several antibody preparation was mixed with PEG
solution (0.02 M, MW 20,000), and the solutions were stood at
4 °C for 12 h. According to the results of powder X-ray diffrac-
tion, α-CyD and γ-CyD successfully formed PPRX hydrogels with
one PEG chain and two PEG chains, respectively, even in the
presence of human IgG (>100 mg/mL) and antibody prepara-
tion. In addition, α-CyD and γ-CyDPPRXs including human IgG
formed the hexagonal or tetragonal columnar necklace-like in-
clusion complex, respectively, resulting in physical cross-
linking points to form the hydrogels (Fig. 1). The imaging data
obtained by Raman spectroscopy indicated that both α-CyD and
* E-mail address: arimah@gpo.kumamoto-u.ac.jp.
Peer review under responsibility of Shenyang Pharmaceutical University.
http://dx.doi.org/10.1016/j.ajps.2015.11.026
1818-0876/© 2016 Production and hosting by Elsevier B.V. on behalf of Shenyang Pharmaceutical University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
a s i an j o u rna l o f p h a rma c eu t i c a l s c i e n c e s 1 1 ( 2 0 1 6 ) 2 2 1 – 2 2 2
Available online at www.sciencedirect.com
journal homepage: www.elsevier.com/ locate /a jps
HOSTED BY
ScienceDirect
γ-CyDwere sparsely dispersed in the hydrogels, whereas human
IgG was homogeneously distributed. In addition, we evalu-
ated the physicochemical stability of human IgG and various
antibody preparations into the PPRX hydrogels after heating
(60 °C, 30 min) or shaking (500 rpm, 1 week). Importantly, the
thermal stability and shaking stability of human Ig Gen cap-
sulated into PEG/CyD PPRX hydrogels were markedly improved,
compared to human IgG alone. Moreover, the shaking stabil-
ity of various antibody preparations encapsulated into PEG/
CyD PPRX hydrogels were improved, compared to antibody
preparation alone.These results obtained in the present study
suggest that PEG/CyDs PPRX hydrogels could be a promising
stabilizing material for highly-concentrated human IgG or an-
tibody preparations.
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Fig. 1 – Schematic proposed structures of α-CyD and γ-CyD PPRX hydrogels including highly-concentrated human IgG.
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